User contributions
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 16:38, 15 April 2010 (diff | hist) . . (-29) . . Joint Attention (→Interventions)
- 16:34, 15 April 2010 (diff | hist) . . (-17) . . Joint Attention (→Joint Attention)
- 15:10, 15 April 2010 (diff | hist) . . (-1) . . Allostatic overload model (→Basic Characteristics) (current)
- 12:21, 14 April 2010 (diff | hist) . . (+1) . . Joint Attention (→Basic Characteristics)
- 14:36, 13 April 2010 (diff | hist) . . (+233) . . Joint Attention (→Interventions)
- 14:25, 13 April 2010 (diff | hist) . . (+58) . . Joint Attention (→Interventions)
- 21:50, 31 March 2010 (diff | hist) . . (+215) . . Social Communication (→Interventions)
- 21:41, 31 March 2010 (diff | hist) . . (+365) . . Social Communication (→Interventions)
- 21:13, 31 March 2010 (diff | hist) . . (+125) . . Social Communication (→Interventions)
- 21:10, 31 March 2010 (diff | hist) . . (+175) . . Social Communication (→Interventions)
- 20:00, 31 March 2010 (diff | hist) . . (+225) . . Social Communication (→Interventions)
- 21:13, 20 November 2009 (diff | hist) . . (+575) . . Serotoninergic, GABAergic, and glutamatergic pathways (→Serotoninergic, GABAergic, and Glutamatergic pathways)
- 20:53, 20 November 2009 (diff | hist) . . (+202) . . Serotoninergic, GABAergic, and glutamatergic pathways
- 21:03, 13 November 2009 (diff | hist) . . (+235) . . Ubiquitin
- 20:43, 13 November 2009 (diff | hist) . . (+71) . . Ubiquitin
- 20:21, 13 November 2009 (diff | hist) . . (+917) . . N Ubiquitin (Created page with '==Ubiquitin pathway (UBE3A, PARK2, RFWD2 and FBXO40)== The genes UBE3A, PARK2, RFWD2 and FBXO40 are a part of the Ubiquitin pathway and have been implicated as genes that may po…')
- 18:32, 13 November 2009 (diff | hist) . . (+178) . . CNVs
- 17:46, 13 November 2009 (diff | hist) . . (+258) . . CNVs
- 16:45, 13 November 2009 (diff | hist) . . (+1,620) . . CNVs
- 15:53, 13 November 2009 (diff | hist) . . (+36) . . CNVs
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)